enVVeno Medical Corp (NVNO) Cash flow

Market cap
$227.97M
P/E ratio
2018/122019/122020/122021/122022/122023/122024/12
Stock-based compensation2941,962693,1096954
Cash from operations -6,355,838-5,896,400-7,677,210-11,845,846-16-19-17
Capital expenditures-12,422-363,891-180,291-367,890-0-0-0
Cash from investing -12,422-363,891-180,291-367,890-35-81
Cash from financing 961558-2614
Free cash flow
FCF margin (%)-----
AI Chat